Updates are available Correction dated 2020-03-23
Click to view Correction: https://doi.org/10.1038/s41418-020-0529-9
-
Authors
Chen, Xiaoyan
Wang, Huiming
Yu, Mengliu
Kim, Jong Kil
Qi, Huichuan
Ha, Pin
Jiang, Wenlu
Chen, Eric
Luo, Xiangyou
Needle, Ryan Brent
Baik, Lloyd
Yang, Cathryn
Shi, Jiejun
Kwak, Jin Hee
Ting, Kang
Zhang, Xinli
Soo, Chia
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Zhejiang Province (LY19H140002)
National Natural Science Foundation of China (81400538)
National Aeronautics and Space Administration (GA-2014-154)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR066782, R01AR068835)
UCLA/NIH CTSI
- License Information
-
More Information
Article History
Received: 25 November 2018
Revised: 9 July 2019
Accepted: 26 August 2019
First Online: 3 October 2019
Change Date: 23 March 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41418-020-0529-9
Compliance with ethical standards
:
: XZ, KT, and CS are inventors of Nell-1 related patents. XZ, KT, and CS are founders and/or previous board members of Bone Biologics Inc./Bone Biologics Corp., which sublicenses Nell-1 patents from the UC Regents, which also hold equity in the company. XZ, KT, and CS = Xinli Zhang, Kang Ting, Chia Soo
